Back to 
BlackRock, Inc.
BlackRock, Inc.
RARE6 quarters
Position history for BlackRock, Inc.'s holdings in ULTRAGENYX PHARMACEUTICAL IN
BlackRock, Inc. holds 7.3M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $152.9M as of 2026-Q1. The position was increased (+10.1% shares). RARE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$152.9M
Current Shares
7.3M
Total Value Change
-$122.1M
Total Shares Change
+763,081
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.